ACH
ACH
US6907321029
Accendra Health, Inc.
Loading chart...

Company Profile

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Latest News

Related stocks

HSIC
HSIC • United States
Henry Schein, Inc.
84.01 USD
9.57B USD 1Y +30.7%
COR
COR • United States
Cencora, Inc.
323.85 USD
61.8B USD 1Y +3.5%
CAH
CAH • United States
Cardinal Health, Inc.
237.57 USD
55.01B USD 1Y +51.5%
MCK
MCK • United States
McKesson Corporation
938.84 USD
109.46B USD 1Y +23.1%
UPR.IR
UPR.IR • Ireland
UNIPHAR PLC
3.84 EUR
1.12B USD 1Y +2.5%
ASKER.ST
ASKER.ST • Sweden
Asker Healthcare Group AB
68.85 SEK
2.64B USD 1Y -20%
ARJO-B.ST
ARJO-B.ST • Sweden
Arjo AB ser. B
27.18 SEK
740.74M USD 1Y -13.2%
9987.T
9987.T • Japan
SUZUKEN CO LTD
2,600 JPY
2.19B USD 1Y -12.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
76.8% p.a.
Max Drawdown (5Y)
-99.1%
Sharpe Ratio (5Y)
-0.78
Beta Factor
1.57
Size Class
Micro Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 1.57 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (84.7%) is noticeably higher than the 5Y average (76.8%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (76.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -99.1% in the extended horizon.
ende